What are the Historical Developments and Current Growth Metrics of the Contrast Enhanced Ultrasound Market?
The contrast enhanced ultrasound market has seen considerable growth due to a variety of factors.
• In recent times, the size of the contrast enhanced ultrasound market has experienced robust growth. The market value is projected to rise from $2.05 billion in 2024 to $2.16 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.1%.
The substantial growth recorded in the historic period can be associated with factors such as the precision and sensitivity of the diagnostic procedures, its non-invasiveness and safety considerations, the rising prevalence of liver ailments, the worldwide increase in the aging demographic, and the growing inclination towards non-radiation techniques.
What Is The Projected Growth Of The Contrast Enhanced Ultrasound Template Market?
The contrast enhanced ultrasound market is expected to maintain its strong growth trajectory in upcoming years.
• The market for contrast enhanced ultrasound is projected to experience significant expansion in the upcoming years, potentially reaching $2.69 billion in 2029 with a compound annual growth rate (CAGR) of 5.7%.
This growth for the forecast period is due to factors like the increase in cardiovascular diseases, the expanded use in pediatric imaging, the broadening role in gastrointestinal imaging, a heightened emphasis on precision medicine, and integration with artificial intelligence. Some major trends throughout the forecast period involve persistent technological innovations, ultrasound technology developments, widening use in oncology, combination with multi-modal imaging, real-time quantitative evaluation, and pediatric applications.
What Are The Key Drivers Fueling Growth In The Contrast Enhanced Ultrasound Market?
The escalating incidence of chronic illnesses is believed to fuel the expansion of the contrast-enhanced ultrasound market in the future. Chronic illnesses are defined as long-lasting health problems that continue for a significant period and require continuous medical treatment and care. Chronic conditions like liver cirrhosis or vascular diseases related to hypertension can be vividly imaged in real time with contrast-enhanced ultrasound, enabling more efficient long term management. The World Health Organization, a specialty agency of the United Nations based in Switzerland, reported in September 2023 that there were 41 million deaths globally each year, with 74% linked to non-communicable diseases (NCDs) or chronic illnesses. Hence, the increasing rate of chronic diseases should boost the contrast-enhanced ultrasound market's growth.
Contrast Enhanced Ultrasound Market Driver: Influence of Ambulatory Surgical Centers on the Expansion of the Contrast-Enhanced Ultrasound Market
What Are The Principal Market Segments In The Global Contrast Enhanced Ultrasound Industry?
The contrast enhanced ultrasound market covered in this report is segmented –
1) By Product: Equipment, Contrast Agent
2) By Technology: Non-targeted, Targeted
3) By Application: Hospitals, Clinics, Other Applications
Subsegments:
1) By Equipment: Ultrasound Machines, Portable Ultrasound Devices
2) By Contrast Agent: Gas-filled Contrast Agents, Microbubble Contrast Agents, Lipid-based Contrast Agents
Pre-Book The Contrast Enhanced Ultrasound Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Contrast Enhanced Ultrasound Market?
Leading firms in the contrast-enhanced ultrasound market are innovating to create advanced technologies, for example, the super-resolution contrast-enhanced ultrasound (CEUS) technology, which boosts the spatial resolution of CEUS imagery. The application of these cutting-edge technologies enhances the diagnostic power of contrast-enhanced ultrasound, aiding medical professionals in yield more in-depth and precise data about the anatomy, functionality, and perfusion of tissues and organs. Philips, a company based in the Netherlands known for developing and manufacturing medical systems and consumer electronics, launched a superior contrast-enhanced ultrasound (CEUS) technology called Philips Microvascular Imaging Super Resolution in September 2023. Utilising sophisticated signal processing algorithms, the technology enhances the spatial resolution of CEUS images. It is beneficial in generating high-definition images of blood vessels and various other structures, aiding in the diagnosis and treatment of a multitude of diseases such as cancer, liver disorders, and vascular diseases.
Who Are the Key Players In The Contrast Enhanced Ultrasound Market?
Major companies operating in the contrast enhanced ultrasound market report are:
• General Electric Company
• Bayer AG
• Bristol-Myers Squibb Company
• Siemens Healthcare GmbH
• Koninklijke Philips N.V.
• Daiichi Sankyo Company Limited
• Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
• J.B. Chemicals and Pharmaceuticals Ltd.
• Canon Medical Systems
• Lantheus Medical Imaging Inc.
• Guerbet
• Bracco Diagnostic Inc.
• Esaote S.p.A.
• Trivitron Healthcare Pvt. Ltd.
• BK Medical Holding Company Inc.
• Hitachi Healthcare
• Chison Medical Technology Co. Ltd.
• SANOCHEMIA Pharmazeutika GmbH
• SuperSonic Imagine SA
• FUJIFILM Visualsonics Inc.
• Leriva Pharma SA
• Samsung Healthcare
• Jodas Expoim Pvt Ltd.
• nanoPET Pharma GmbH
• Alpinion Medical Systems
• Acusphere Inc.
• ContextVision AB
• Teratech Corporation
• Solstice Pharmaceuticals B.V.
What Are The Regional Insights Into The Contrast Enhanced Ultrasound Market?
North America was the largest region in the contrast-enhanced ultrasound market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contrast enhanced ultrasound market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
